课题基金 / 基金详情

MECHANISM OF AIRWAY INFLAMMATION: VIRAL RESPIRATORY TRACT INFECTION ASSOCIATED

MECHANISM OF AIRWAY INFLAMMATION: VIRAL RESPIRATORY TRACT INFECTION ASSOCIATED
气道炎症机制:与病毒呼吸道感染相关
批准号:
7603387
负责人:
Mario Castro
金额:
$0.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2007-09-16

项目摘要

项目成果

Mario Castro的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The viral RTI associated with wheezing protocol will allow us to investigate the role of common respiratory viruses, RSV, parainfluenza, rhinovirus, and adenovirus, have during an acute RTI (serious enough to warrant hospitalization), during convalescence (two months later), and finally in those that do or do not develop persistent wheezing (three years later). We have chosen these select respiratory viruses due to their potential link with the development of asthma, or as potential cause of transient wheezing, or due to their potential role of subverting the interferon- immune response. We will utilize blood and upper airway epithelial cells for activated Stat 1 in these children with viral RTI associated with wheezing by examining airway epithelial cells for activated Stat 1. Since activated Stat 1 is constitutively activated in asthmatic subjects and RSV infection (presumably interferon-gamma) can activate Stat 1, the persistence of high levels of activated Stat 1 in early life following a serious RTI associated with wheezing may be a marker for the development of asthma. This protocol will allow these molecular and cellular mechanisms of asthma to be investigated in a human model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Kansas' Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE) Clinical Center
University of Kansas' Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE) Clinical Center
WASHINGTON UNIVERSITY'S PRECISION BIOLOGIC INTERVENTIONS FOR SEVERE EXACERBATION PRONE ASTHMA (PRECISE) CLINICAL CENTER
  • 批准号:
    9751957
  • 项目类别:
  • 资助金额:
    $6.53万
  • 财政年份:
    2017
  • 负责人:
    Mario Castro
  • 依托单位:
Frontiers Clinical and Translational Science Institute at the University of Kansas
海外基金